Home / Health News / New Ebola Test Produces Results In Remote Areas

New Ebola Test Produces Results in Remote Areas


FRIDAY, Nov. 9, 2018 (HealthDay News) -- The U.S. Food and Drug Administration has approved emergency use of a new Ebola fingerstick test, which includes a reader that makes it possible to obtain results outside a laboratory.

The DPP Ebola Antigen System makes obtaining test results possible in remote areas with limited lab resources, such as those in African nations affected by Ebola outbreaks, the agency said Friday in a news release.

"The scourge of Ebola tragically demonstrates that we're a global community when it comes to public health protection. Infectious disease doesn't recognize nation states," said FDA Commissioner Dr. Scott Gottlieb.

The emergency declaration permitting the test's use was made in response to an Ebola outbreak in the central-African nation of the Congo, the FDA said.

The agency cautioned that test results shouldn't be the only criterion used to determine a patient's course of treatment. Medical professionals also should consider a patient's history, vital signs, symptoms and likelihood of exposure, the FDA said.

The test is produced by Chembio Diagnostic Systems, based in Medford, N.Y.

More information

The FDA has more about this action.

« Back to News
 

The news stories provided in Health News and our Health-E News Newsletter are a service of the nationally syndicated HealthDay® news and information company. Stories refer to national trends and breaking health news, and are not necessarily indicative of or always supported by our facility and providers. This information is provided for informational and educational purposes only, and is not intended to be a substitute for medical advice, diagnosis, or treatment.